Diem Nguyen - Oct 13, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Director
Signature: /s/ Jason A. Amello, as Attorney-In-Fact for Diem Nguyen
Stock symbol: CADL
Transactions as of: Oct 13, 2022
Transactions value $: $0
Form type: 4
Date filed: 10/17/2022, 04:45 PM
Previous filing: Jun 13, 2022
Next filing: Jun 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CADL	Stock Option (Right to Buy)	Award	$0	+14.2 K		$0.00	14.2 K	Oct 13, 2022	Common Stock	14.2 K	$2.81	Direct	F1

Explanation of Responses:

Id	Content
F1	This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.

Content

This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.

Remarks:

Exhibit 24 - Power of Attorney